The cellular mechanisms of valvular heart disease have not been
elucidated until the last decade. To date, there is no medical
therapy that is FDA or CE mark approved for the treatment and/or
slowing the progression of this disease. This textbook will provide
the cellular basis for medical therapy. Over the past decade,
research laboratories are more and more evolving into valvular
biology programs from the traditional vascular biology. The science
between the two disciplines, although has several similarities has
unique cellular targets secondary to the embryologic derivation of
the heart valve and the hemodynamics involved in the understanding
of this disorders. This textbook will be a natural progression from
the recently published text Cardiac Valvular Medicine, Springer
2012. This new textbook will provide the cellular details and the
more basic molecular biology approaches towards understanding the
disease, providing novel cellular targets and finally developing
future clinical trials in the medical treatment of valvular heart
disease in the future.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!